Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Formulation containing honeysuckle flower and scutellaria, and uses thereof

A silvery yellow and multipurpose technology, which is applied in the field of silvery yellow preparations and its uses, can solve the problem of less silvery yellow preparations, achieve the effect of less medicinal taste, complete extraction, and enhanced curative effect

Inactive Publication Date: 2009-05-27
BEIJING CENT BIOLOGY
View PDF15 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0016] However, in the veterinary field, there are still few silver yellow preparations available, and there is no report on the use of silver yellow preparations for the treatment of mycoplasma gallisepticum infection and swine asthma

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Formulation containing honeysuckle flower and scutellaria, and uses thereof
  • Formulation containing honeysuckle flower and scutellaria, and uses thereof
  • Formulation containing honeysuckle flower and scutellaria, and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Embodiment 1: Preparation process of silver yellow soluble powder of the present invention

[0024] Specific steps:

[0025] Weigh 48.0g of honeysuckle extract, 32.0g of Scutellaria baicalensis extract, 40g of sodium bicarbonate, add glucose to 1000g, mix evenly, subpackage, and obtain drug 1.

[0026] Weigh 900.0g of honeysuckle extract, 10.0g of Scutellaria baicalensis extract, 20g of sodium bicarbonate, add glucose to 1000g, mix evenly, subpackage, and obtain drug 2.

[0027] Weigh 40g of honeysuckle extract, 20g of Scutellaria baicalensis extract, and 20g of sodium bicarbonate;

Embodiment 2

[0028] Embodiment 2: preparation technology of Yinhuang oral liquid of the present invention

[0029] Specific steps:

[0030] Weigh 48.0g of honeysuckle extract and 32.0g of Scutellaria baicalensis extract, add 600ml of purified water, stir to form a suspension, adjust the pH value to 5.0~7.0 with sodium hydroxide solution to dissolve, add purified water to 1000ml, and divide installed, vested drugs 4.

[0031] Weigh 900.0g of honeysuckle extract and 10.0g of Scutellaria baicalensis extract, add 600ml of purified water, stir to form a suspension, adjust the pH value to 5.0~7.0 with sodium hydroxide solution to dissolve, add purified water to 1000ml, and divide installed, vested drugs 5.

[0032] Weigh 40g of honeysuckle extract, 20g of Scutellaria baicalensis extract, add 600ml of purified water, stir to form a suspension, adjust the pH value to 5.0~7.0 with sodium hydroxide solution to dissolve, add purified water to 1000ml, and pack, Acquired drugs6.

Embodiment 3

[0033] Embodiment 3: preparation technology of Yinhuang injection of the present invention

[0034] Specific steps:

[0035] Weigh 16.0g of honeysuckle extract and 10.0g of Scutellaria baicalensis extract, add 600ml of water for injection, stir to form a suspension, adjust the pH value to 5.0~7.0 with sodium hydroxide solution to dissolve, add water for injection to the full amount, and Filter through a pore filter, pack in ampoules, melt seal, sterilize at 115°C for 30 minutes, inspect with lights, pack, and obtain medicines 7.

[0036] Weigh 300.0g of honeysuckle extract and 4.0g of Scutellaria baicalensis extract, add 600ml of water for injection, stir to form a suspension, adjust the pH value to 5.0~7.0 with sodium hydroxide solution to dissolve, add water for injection to the full amount, and Filter through a pore filter, pack in ampoules, melt seal, sterilize at 115°C for 30 minutes, inspect with lights, pack, and obtain medicines 8.

[0037] Weigh 14.5g of honeysuckle...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a Yinhuang Preparation and a usage thereof and further relates to a Yinhuang composition which is composed of honeysuckle extract and a Baikal skullcap root extract. The invention also relates to the usage of the composition in the preparation of drugs for curing chronic respiratory disease infection of beasts and birds.

Description

technical field [0001] The invention relates to a silvery yellow composition and its use in the preparation of medicines for treating livestock chronic respiratory infectious diseases. Background technique [0002] Chicken chronic respiratory disease (CRD) is a chronic respiratory infectious disease of chickens caused by Mycoplasma gallisepticum (MG) infection. Because MG is distributed in countries all over the world and can be transmitted horizontally and vertically, it can exist and spread for a long time in chicken flocks. According to the serological survey, the infection rate of chicken flocks is 70% to 80%. The mortality rate of this disease is generally not high, but when secondary or complicated by other diseases, the mortality rate can be as high as more than 40%. According to statistics, after MG infects chicken flocks, the weak chick rate of chicks increases by about 10%, the laying rate of laying hens decreases by 10% to 20%, the body weight of broilers decrea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/539A61K9/08A61K9/10A61K9/14A61P11/00
Inventor 江厚生王秀敏崔晓霞
Owner BEIJING CENT BIOLOGY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products